中文名稱：兔抗FYCO1多克隆抗體

英文名稱： Anti-FYCO1 rabbit polyclonal antibody

別名： FYVE and coiled-coil domain containing 1; CATC2; RUFY3; ZFYVE7; CTRCT18

抗原： FYCO1

儲存： 冷凍（-20℃）

宿主： Rabbit

反應(yīng)種屬： Human

相關(guān)類別：一抗

標(biāo) 記物： Unconjugate

克隆類型： rabbit polyclonal

技術(shù)規(guī)格

Background:

This gene encodes a protein that contains a RUN domain, FYVE-type zinc finger domain and Golgi dynamics (GOLD) domain. The encoded protein plays a role in microtubule plus end-directed transport of autophagic vesicles through interactions with the small GTPase Rab7, phosphatidylinositol-3-phosphate (PI3P) and the autophagosome marker LC3. Mutations in this gene are a cause of autosomal recessive congenital cataract-2 (CATC2).

Applications:

ELISA, IHC

Name of antibody:

FYCO1

Immunogen:

Fusion protein of human FYCO1

Full name:

FYVE and coiled-coil domain containing 1

Synonyms:

CATC2; RUFY3; ZFYVE7; CTRCT18

SwissProt:

Q9BQS8

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human liver cancer and Human cervical cancer

IHC Recommend dilution:

100-200

展開全部

兔抗FYCO1多克隆抗體說明書
下載

久久综合九九-久久综合九九亚洲一区-久久综合九色-久久综合九色欧美综合狠狠-久久综合九色婷婷97-久久综合九色综合8888

021-54845833/15800441009

ELISA試劑盒

PCR試劑盒

生化試劑盒

細(xì)胞系

細(xì)胞庫

基礎(chǔ)培養(yǎng)基

完全培養(yǎng)基

原代細(xì)胞

細(xì)胞專用培養(yǎng)基

菌株

生化試劑

病理染色液

科研抗體

標(biāo)準(zhǔn)品

血清

產(chǎn)品中心

最新產(chǎn)品

相關(guān)文章

兔抗FYCO1多克隆抗體

Background:	This gene encodes a protein that contains a RUN domain, FYVE-type zinc finger domain and Golgi dynamics (GOLD) domain. The encoded protein plays a role in microtubule plus end-directed transport of autophagic vesicles through interactions with the small GTPase Rab7, phosphatidylinositol-3-phosphate (PI3P) and the autophagosome marker LC3. Mutations in this gene are a cause of autosomal recessive congenital cataract-2 (CATC2).
Applications:	ELISA, IHC
Name of antibody:	FYCO1
Immunogen:	Fusion protein of human FYCO1
Full name:	FYVE and coiled-coil domain containing 1
Synonyms:	CATC2; RUFY3; ZFYVE7; CTRCT18
SwissProt:	Q9BQS8
ELISA Recommended dilution:	5000-10000
IHC positive control:	Human liver cancer and Human cervical cancer
IHC Recommend dilution:	100-200